ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
57 hedge funds and large institutions have $21.1M invested in ENZON PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 12 closing their positions.
12% less funds holding
Funds holding: 65 → 57 (-8)
14% less capital invested
Capital invested by funds: $24.6M → $21.1M (-$3.5M)
45% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 22
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$245K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
+$119K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$59K |
| 4 |
KBC Group
Brussels,
Belgium
|
+$55.6K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.19M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$957K |
| 3 |
MFP
Michael F. Price
|
-$367K |
| 4 |
FPA
First Pacific Advisors
El Segundo,
California
|
-$339K |
| 5 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
-$324K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Dimensional Fund Advisors
Austin,
Texas
| – | -$1.19M | -1,099,525 | Closed |
|
|
52
Schroder Investment Management Group
London,
United Kingdom
| – | -$957K | -886,500 | Closed |
|
|
MFP
53
Michael F. Price
| – | -$367K | -340,000 | Closed |
|
|
MERSOM
54
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
| – | -$324K | -299,600 | Closed |
|
|
WBC
55
Westpac Banking Corp
Sydney,
Australia
| – | -$241K | -223,298 | Closed |
|
|
FQ
56
First Quadrant
Glendale,
California
| – | -$88K | -81,700 | Closed |
|
57
Jane Street
New York
| – | -$72K | -66,654 | Closed |
|
58
Citadel Advisors
Miami,
Florida
| – | -$25K | -23,379 | Closed |
|
59
D.E. Shaw & Co
New York
| – | -$15K | -14,073 | Closed |
|
|
LP
60
LMR Partners
London,
United Kingdom
| – | -$13K | -11,250 | Closed |
|
61
Citigroup
New York
| – | -$49 | -47 | -14% |
|
62
BNP Paribas Financial Markets
Paris,
France
| – | -$38 | -35 | Closed |
|
63
Bank of America
Charlotte,
North Carolina
| – | +$2 | +2 | +200% |
|
|
RMAM
64
Raab & Moskowitz Asset Management
Chatham,
New Jersey
| – | +$262 | +250 | New |
|
ENZN Hedge Fund Activity: Q4 2014 in Review
57 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q4 2014, worth a combined $21.1M — down 14% from $24.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ENZN and 5 opened new positions — a net loss of 7 holders — while 22 trimmed existing stakes and 12 added.
The largest buyer was Renaissance Technologies, adding an estimated $245K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $1.19M sold.
- 57 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q4 2014, down from 65 in Q3 2014.
- Funds reported $21.1M of ENZON PHARMACEUTICALS INC stock for Q4 2014, down 14% quarter-over-quarter.
- 5 funds opened new ENZON PHARMACEUTICALS INC positions in Q4 2014 and 12 closed out, a net change of -7 holders.
- The largest ENZON PHARMACEUTICALS INC buyer in Q4 2014 was Renaissance Technologies, an estimated $245K added.
- The largest ENZON PHARMACEUTICALS INC seller in Q4 2014 was Dimensional Fund Advisors, an estimated $1.19M sold.
Based on aggregated 13F filings for Q4 2014.